These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 1964891)
1. Pharmacological and toxicological activities of a new methylxanthine derivative [7-(1,3-dithiolan-2-ylmethyl)1,3-dimethylxanthine] with antibronchospastic and mucoregulatory properties. Franzone JS; Reboani MC; Biglione V; Cirillo R Drugs Exp Clin Res; 1990; 16(6):263-76. PubMed ID: 1964891 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological researches on 2-(7'-theophyllinemethyl)1,3-dioxolane. Franzone JS; Reboani C; Fonzo D; Di Carlo R Farmaco Sci; 1981 Mar; 36(3):201-19. PubMed ID: 6262105 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological studies in animals of beta-hydroxyethyltheophylline, the major metabolite of doxofylline in humans. Franzone JS; Cirillo R; Reboani MC Methods Find Exp Clin Pharmacol; 1991 May; 13(4):289-99. PubMed ID: 1652045 [TBL] [Abstract][Full Text] [Related]
4. Kinetic and metabolic studies of 7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine in the rat. Cravanzola C; Grosa G; Franzone JS Drugs Exp Clin Res; 1990; 16(6):285-91. PubMed ID: 2086163 [TBL] [Abstract][Full Text] [Related]
5. In vivo anti-inflammatory activity of 7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine. Reboani MC; Franzone JS Drugs Exp Clin Res; 1990; 16(6):277-84. PubMed ID: 2086162 [TBL] [Abstract][Full Text] [Related]
6. Doxofylline and theophylline are xanthines with partly different mechanisms of action in animals. Franzone JS; Cirillo R; Barone D Drugs Exp Clin Res; 1988; 14(7):479-89. PubMed ID: 3240706 [TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic profile of isbufylline, a new antibronchospastic xanthine devoid of central excitatory actions. Manzini S; Meini S; Giachetti A; Beani L; Borea PA; Antonelli T; Ballati L; Bacciarelli C Arzneimittelforschung; 1990 Nov; 40(11):1205-13. PubMed ID: 1707621 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of 7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine by rat liver microsomes. Diastereoselective metabolism of the 1,3-dithiolane ring. Grosa G; Caputo O; Ceruti M; Biglino G; Franzone JS; Cravanzola C Drug Metab Dispos; 1991; 19(2):454-7. PubMed ID: 1676653 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of a new antiasthmatic xanthine derivative devoid of central stimulatory activity. Duhault J; Boulanger M; Lonchampt M; Tisserand F; Holstorp S; Saint-Romas G; Pennel L; Regnier G Arzneimittelforschung; 1987 Dec; 37(12):1353-62. PubMed ID: 2835053 [TBL] [Abstract][Full Text] [Related]
10. [The semisynthetic production of pharmacologically active flavone derivatives. I. The pharmaco-toxicological properties of theophylline-rutozide (TR 1722)]. Dănilă G; Nechifor M Rev Med Chir Soc Med Nat Iasi; 1990; 94(1):151-6. PubMed ID: 2075319 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic profile of the new potent antibronchospastic agent 7-[(2,2-dimethyl)propyl]-1-methyl xanthine. Evangelista S; Ballati L; Boni P; Castellucci A; Perretti F; Tramontana M; Toja E Arzneimittelforschung; 1995 May; 45(5):569-75. PubMed ID: 7612055 [TBL] [Abstract][Full Text] [Related]
12. Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione, 3,7-dihydro-3-methyl-7[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]. 2nd communication: investigations on theophylline-like activities. Mikus EG; Kapui Z; Korbonits D; Boér K; Boronkay E; Gyürky J; Révész J; Lacheretz F; Pascal M; Arányi P Arzneimittelforschung; 1997 Dec; 47(12):1358-63. PubMed ID: 9450164 [TBL] [Abstract][Full Text] [Related]
13. [The effect of microencapsulation on the pharmacological activity of theophylline and euphylline]. Andreeva IN; Saraf AS; Makarov VA Farmakol Toksikol; 1991; 54(5):27-9. PubMed ID: 1800140 [No Abstract] [Full Text] [Related]
14. Design and synthesis of some new theophylline derivatives with bronchodilator and antibacterial activities. Hayallah AM; Elgaher WA; Salem OI; Alim AA Arch Pharm Res; 2011 Jan; 34(1):3-21. PubMed ID: 21468910 [TBL] [Abstract][Full Text] [Related]
15. Doxofylline differs from methylxanthines in its movement of cytosolic calcium. Franzone JS; Cirillo R; Reboani MC Int J Tissue React; 1991; 13(3):131-8. PubMed ID: 1960014 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of theophylline, theophylline-7-acetic acid, ambroxol and ambroxol-theophylline-7-acetate on rat lung cAMP phosphodiesterase isoenzymes. Ferretti C; Coppi G; Blengio M; Genazzani E Int J Tissue React; 1992; 14(1):31-6. PubMed ID: 1328102 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological and toxicological studies of an original xanthine derivative with bronchodilatating activity. Staneva D; Chakurova L; Ivanova N; Spasov V; Raynova L; Bogoslovova T Acta Physiol Pharmacol Bulg; 1984; 10(4):44-52. PubMed ID: 6535369 [TBL] [Abstract][Full Text] [Related]
18. Bronchodilatory activity and pharmacokinetics of new xanthines in guinea-pigs. Takagi K; Hasegawa T; Nadai M; Sakai R; Miyamoto K Clin Exp Pharmacol Physiol; 1992 Jun; 19(6):447-56. PubMed ID: 1318809 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological studies on BB-1502, a new bronchodilator. Kamei H; Hirano M; Kawano K; Murata S; Imanishi H; Kawaguchi H Jpn J Pharmacol; 1981 Jun; 31(3):333-46. PubMed ID: 6273627 [TBL] [Abstract][Full Text] [Related]
20. Doxofylline in rat brain in relation to locomotor activity. Cravanzola C; Reboani MC; Grosa G; Franzone JS Drug Metab Dispos; 1989; 17(4):437-40. PubMed ID: 2571486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]